EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 5, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Tim Buchmiller Office of Life Sciences |
| Re: | Withdrawal of Acceleration Request OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-284631) |
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated (the “Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, February 4, 2025.
The Company is no longer requesting that such Registration Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally withdraw our request for acceleration of the effective date.
Thank you for your assistance.
| Very truly yours, | ||
| /s/ Spencer G. Feldman | ||
| Spencer G. Feldman | ||
| cc: | Paul A. Romness, MPH | |
February 5, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Tim Buchmiller Office of Life Sciences |
| Re: | Withdrawal of Acceleration Request OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-284631) |
Ladies and Gentlemen:
OS Therapies Incorporated hereby withdraws the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, February 4, 2025.
We are no longer requesting that such Registration Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally withdraw our request for acceleration of the effective date.
|
|
Very truly yours, | |
| OS Therapies Incorporated | ||
| By: |
/s/ Paul A. Romness | |
| Paul A. Romness | ||
| President and Chief Executive Officer | ||